In the ever-turning wheel of biomedical innovation, there’s a new spoke that may change how discoveries reach patients.
NIH’s New Patent Licensing Policy: Misguided?
1 min read Premium comments

PremiumIntramural Research Program Access Planning PolicyIRPNational Institutes of Health#nih
React:
